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INTRODUCTION
The self-renewal versus differentiation of neural precursor cells (NPCs) is determined by the interplay between intrinsic mechanisms and the microenvironment where they reside. This microenvironment is comprised, in part, of growth factors secreted by neighboring cells like other NPCs, glial cells, and neurons that are present in the circulation and cerebrospinal fluid (GauthierFisher and Miller, 2013) . Previous work has defined individual ligands that regulate embryonic and adult NPCs, including neurotransmitters (Haydar et al., 2000) , circulating growth factors (Villeda et al., 2011) , and locally produced growth factors like FGF2 and IL-6 (Gallagher et al., 2013; Raballo et al., 2000) . Nonetheless, we still lack an overview of the NPC growth factor microenvironment.
How might we obtain such an overview? We have chosen to do so by combining transcriptomic and proteomic profiling to analyze the embryonic murine cortex during the period of neurogenesis. At this time, cortical radial precursors are maintained in a neuroepithelium, with their apical endfeet forming the interface with the lateral ventricles, and their basal processes extending to the cortical surface. These radial precursors generate neurons that delaminate from the apical epithelium and migrate basally in intimate contact with the radial precursor processes (Noctor et al., 2001) . To understand the growth factors that are important during this process, we have focused upon these two cell types, radial precursors and their newborn neuronal progeny, and have used an iterative systems biology strategy. We show that cultured cortical precursors secrete factors that promote their own maintenance, while cortical neurons secrete factors that promote neurogenesis. To identify these secreted factors, we defined the transcriptome and cell-surface proteome of cultured cortical precursors and neurons and used these data to model the growth factor communication within and between these two populations. This model predicts a complex growth factor communication network that provides the basis for multiple potential autocrine and paracrine interactions. We tested this model by focusing on growth factors that might enhance neurogenesis, and in so doing, have identified three factors, IFNg, Nrtn, and GDNF, that are necessary and sufficient for the neurogenic differentiation of radial precursor cells in vivo.
RESULTS

Factors Secreted by Cultured Cortical Precursors and
Their Neuronal Progeny Regulate Self-Renewal versus Differentiation During neurogenesis, the cortex is largely comprised of radial precursors and newborn neurons. To identify secreted ligands (C and D) E13 precursors were cultured 3 days at 7,000-440,000 cells/cm 2 , immunostained for Ki67 (red, arrowheads in C), and/or bIII-tubulin (bIII, green, arrows in C) and quantified (D). Cultures were also quantified for condensed, apoptotic nuclei (D). n = 3 experiments.
(legend continued on next page) within this microenvironment, we studied embryonic day 13 (E13) cortical cultures that are comprised of proliferating Sox2 and Pax6-positive radial precursors, and a small number of intermediate progenitors, the neurogenic transit-amplifying cells in this system (Gauthier-Fisher et al., 2009; Gallagher et al., 2013) . These cultured precursors generate neurons for 4-5 days and then switch to making glia at 6-7 days. Immunostaining confirmed this cellular composition after 20 and 72 hr of culture ( Figures 1A and 1B ). There were no CD31-positive blood vessel cells, Iba1-positive microglia, GFAP-positive astrocytes, or MBP-positive oligodendrocytes at either time point. Instead, at 20 hr about 75% and 25% of the cells were Pax6-positive radial precursors and bIII-tubulin-positive neurons, respectively. By 72 hr, radial precursors had decreased to about 55%, and neurons had increased. At both time points, 6%-9% of cells were Tbr2-positive intermediate progenitors.
We asked whether these cultures were density dependent by plating E13 precursors for 3 days at 7,000 to 440,000 cells/cm 2 . Immunostaining (Figures 1C and 1D) showed that at low cell densities (7,000 to 28,000 cells/cm 2 ), most precursors differentiated into neurons. As densities increased, the relative proportion of neurons decreased, until at densities R110,000 cells/cm 2 , only 20%-30% of cells were neurons, while 65%-75% were proliferating Ki67-positive precursors. Survival was also increased at higher cell densities ( Figure 1D ). To ask whether these density-dependent effects were due to secreted molecules, we collected medium conditioned by high-density cultures (110,000 cells/cm 2 ) for 3 days. At the time we collected the medium, about 23% of cells were neurons and the rest were precursors. We applied this conditioned medium to E13 precursors cultured at low density (14,000 cells/ cm 2 ). Immunostaining after 3 days (Figures 1E and 1F) showed that in control medium, about 70% and 30% of cells were neurons and proliferating precursors, respectively. In contrast, conditioned medium from high-density cultures reduced this to about 40% neurons and 60% proliferating precursors, proportions similar to those in high-density cultures ( Figure 1D ). Survival, however, was only modestly reduced by high-density conditioned medium ( Figure 1F ). Since high-density cultures are mostly precursors, these data indicate that they secrete molecules to enhance their own expansion.
Newborn Cortical Neurons Secrete Factors that Promote Cortical Neurogenesis
We next asked whether newborn cortical neurons also secrete factors that influence cortical precursor biology. To do this, we transfected E13 precursors with plasmids encoding the piggybac (PB) transposase and a PB-EGFP reporter that indelibly marks a subset of precursors and all of their progeny (Gallagher et al., 2013) . We then isolated and cultured E16 cortical neurons for 4 days. Immunostaining ( Figures 1G and 1H ) confirmed that almost all cells were bIII-tubulin-positive neurons, with no Iba1-positive microglia, CD31-positive endothelial cells, Pax6-positive radial precursors, CC1-or MBP-positive oligodendrocytes, and only a very few cells expressing the astrocyte marker GFAP, the glial precursor marker Olig2, or Ki67. We mixed these unlabelled cortical neurons with the transfected, labeled precursors at a ratio of 6:1 precursors to neurons. Immunostaining 1 day later showed that adding unlabelled neurons increased the genesis of EGFP-positive neurons, and concomitantly decreased the EGFP-positive, proliferating Ki67-positive precursors ( Figures 1I-1K ). To ask whether this proneurogenic effect was due to factors secreted by the added neurons, we prepared conditioned medium from the purified cultured neurons and added it, with FGF2 (which is in the basal precursor medium), to freshly plated E13 precursors. Analysis 3 days later showed that, relative to control medium containing FGF2, neuron-conditioned medium increased newborn neurons and decreased proliferating precursors ( Figure 1L ).
Computational Modeling of Transcriptome Data to Predict Growth Factor Communication within and between Cortical Precursors and Neurons
These data indicate that cortical neurons and precursors secrete factors that promote neurogenesis and proliferation, respectively. To identify the relevant ligands, we used a computational modeling method that makes use of microarray-based transcriptomic data to predict autocrine/paracrine interactions (Qiao et al., 2014) . Initially, we performed microarrays on cortical precursors and neurons. For the neurons, we used 5 day cultures, when they were almost a pure neuronal population (see Figures  1G and 1H) . For the precursors, we grew E13 cultures at 100,000 cells/cm 2 for 20 hr, at which point they were 75% radial precursors, 5%-10% intermediate progenitors, and 20% newborn neurons (called enriched precursors from hereon) ( Figure S1A ). We also analyzed a culture containing precursors mixed with purified cortical neurons at a 6:1 ratio. For each population, we isolated total RNA from three independent biological replicates and analyzed it on Affymetrix GeneChip Mouse Gene 2.0 ST Arrays.
This analysis showed that 1,479 genes were at least 2-fold differentially expressed when comparing neurons and enriched precursors (p < 0.05 FDR) ( Figure 2A ; Table S1 ). Unbiased (E and F) E13 precursors were cultured 3 days at low density (14,000 cells/cm 2 ) in control medium (Con), or in medium conditioned by high-density (110,000 cells/ cm 2 ) precursor cultures (HDCM), immunostained for Ki67 (red, arrowheads, E) and bIII-tubulin (green, arrows, E), and quantified (F). Cultures were also quantified for condensed, apoptotic nuclei (Cond. Nuclei, F). *p < 0.05, **p < 0.01, n = 3 experiments.
(G) Representative image of purified cortical neurons immunostained for bIII-tubulin (arrows, green). hierarchical clustering using the complete-linkage method of an Euclidean distance matrix of log 2 normalized expression data showed that the neuron and enriched precursor replicates each clustered closely and that the mixed population clustered closest to the enriched precursors, likely because the mixed cultures contained more precursors than neurons (20%-25% newborn neurons in the enriched precursors plus 16% added neurons) (Figure 2A ). Gene ontology (GO) analysis showed Figure S1 .
that, as predicted, differentially expressed genes in neurons versus precursors were highly enriched for processes such as cell cycle, neurogenesis, generation of neurons, and neuron differentiation ( Figure S1B ). Thus, this approach readily distinguished neurons from enriched precursors. We next defined the growth factor and receptor mRNAs in these datasets using a curated database of secreted ligands and their cognate receptors (Qiao et al., 2014) (Table S2) . Cortical neurons and enriched precursors expressed 338 ligand mRNAs (Table S3) , of which 244 were expressed at similar levels in both populations. However, 59 and 35 ligand genes were expressed more highly in neurons and precursors, respectively ( Figure 2B ; Table S4 ), with expression differences from 2-to 17-fold ( Figure 2C ). The most highly enriched neuronal ligands included SPARCL1 (hevin), inhibin bA (as a homodimer, called activin A), growth arrest-specific 6 (Gas6), CCL17 (TARC), and neuregulin 3. The most highly enriched precursor ligands included interleukin 1a, interleukin 1b, midkine (mdk), the Notch ligand Jagged, and the Frizzled 4 ligand Norrin (ndp).
Neurons and precursors also expressed 348 receptor mRNAs (Table S3) , with 197 expressed at similar levels. 71 and 80 receptor mRNAs were enriched in neurons and precursors, respectively ( Figure 2B ; Table S4 ), with expression differences of 2-to 11-fold ( Figure 2D ). Receptor mRNAs most highly enriched in neurons included neuropeptide receptors for NPY, neurotensin, and hypocretin and neurotransmitter receptors such as the ionotropic glutamate receptors 2a and 2b. The most highly enriched precursor receptors included Notch 1 and 2, Frizzled 2, and FGF receptors 1 and 3.
We used these transcriptome data to assemble a cortical precursor/cortical neuron communication model (see flow chart in Figure S1C ). Initially, we used a perturbation statistical model (PERT) (Qiao et al., 2012) that analyzes gene expression measurements of individual cells alone and when mixed together to calculate how their profiles might change in a heterogeneous environment such as the embryonic cortex. For example, some cytokines upregulate expression of their receptors, so in a mixed population where one population expresses the cytokine and the other the receptor, paracrine cytokine exposure would increase receptor mRNA in the second population. A comparison with the purified populations allows the mixed profile to be deconvolved into its constituent parts and allows the expression profiles of each individual gene to be corrected for the more biologically relevant mixed population conditions. We used the corrected neuron and enriched precursor reference gene expression profiles together with the curated ligand and receptor database and our previously published methodology for assembling cell interaction networks (Qiao et al., 2014 ; see the flow chart in Figure S1C ) to construct an autocrine/paracrine communication network for the cortical precursor/neuron interactions ( Figure 2F ; Table S5 ). In the resultant model, each node is a secreted ligand and each line is a direction of communication from precursor to precursor, neuron to neuron, precursor to neuron, or neuron to precursor. Ligands predicted to be autocrine (acting within the same population of cells) for cortical precursors and cortical neurons are denoted CP and CN, respectively. Ligands denoted as autocrine for both populations (and there are many) could also potentially function in a paracrine fashion. Ligands that are predicted specifically as paracrine (from one cell type to another) are shown as nodes located between the neurons and precursors.
This model supports a number of conclusions. First, it predicts a large number of potential ligand-receptor interactions between the two populations ( Figure 2F ; Table S5 ), many of which are known to be important for cortical precursors, including FGF2, EGF, Wnt ligands, neurotrophins, PDGFs, ligands of the gp130 family, BMPs, and Notch (Gauthier-Fisher and Miller, 2013) . However, this model also predicts many potential ligand-receptor interactions not previously considered within a neural precursor context such as those involving Gastrin Releasing Peptide (GRP) and CCL3 (macrophage inflammatory protein-1a). Second, these data showed that most ligand and receptor mRNAs are expressed at statistically similar levels in neurons and enriched precursors (Figures 2B and 2F; Table S5 ). Third, because of the large overlap in precursor and neuron ligands and receptors, the model predicts that many interactions would be both autocrine and paracrine, with only 51 limited to a directional paracrine signal. Of these, 16 involved differentially expressed ligands with 11 enriched in neurons, including cholecystokinin (CCK), fractalkine (CX3CL1), and GRP, and five in precursors, including CCL3, Ephrin-B1, and bone-morphogenetic protein 1 (BMP1) ( Figure 2E ).
Finally, we asked whether any of the receptors and ligands in this model were highly co-expressed, as might be predicted by their function in a cell-cell communication network, using weighted correlation network analysis (WGCNA). WGCNA on the nine ligand/receptor datasets (three each from precursors, neurons, and the mixed cells) identified clusters of coexpressed receptors and ligands ( Figure S1D ; Table S5 ). By comparison, WGCNA on a similar number of randomly selected genes in the parent microarray datasets did not generate these coexpression modules ( Figure S1E ). These modules were relevant for both precursors and neurons, as shown by overlaying them on the communication network ( Figure S1F ), and included ligand/receptor groups known to be important in the embryonic cortex, including, in the cluster color-coded turquoise, the neurotrophins (NT3, BDNF, NGF, TrkB, TrkC), the insulin/IGF family (IGF1, IGF1R, IGF2R, insulin receptor), and PDGFs (PDGFA, PDGFB, PDGFC, PDGFRb). Intriguingly, some unanticipated ligand/receptor families were also co-expressed in this cluster, including IFNg (IFNg, IFNgRa, IFNgRb) and the GDNF family (GDNF, persephin, GFRa1, GFRa2, GFRa4, Ret).
Cell-Surface Proteomics to Refine the Cortical Precursor and Neuron Communication Model
One disadvantage of a transcriptome-based model is that the correlation between mRNA abundance and protein expression levels is weaker for cell-surface proteins such as growth factor receptors than for proteins in other compartments (Lundberg et al., 2010) . We therefore characterized the cell-surface proteome of cortical neurons and enriched precursors. To do this, we performed periodate oxidation of cell-surface glycans on cultured cells using established methods to couple glycosylated proteins to a hydrazide resin (McDonald et al., 2009; Schiess et al., 2009 ). The coupled, selectively modified glycosylated cell-surface proteins were then tryptically digested, glycopeptides released by PNGase F, and peptides identified by mass (legend continued on next page) spectrometry. For each sample, we analyzed three independent biological replicates. This analysis identified 1,506 and 1,571 proteins on cortical neurons and precursors, respectively (Table  S6 ). GO analysis of these proteins using PANTHER identified high enrichment for terms associated with the exterior of cells/ vesicles as well as membrane-bound components as expected for cell-surface proteins ( Figure S2A ; Table S7 ). Further analysis using PANTHER classified, in both neurons and precursors, over 200 proteins as receptors, and about 100 as transporters (Figure 3A ; Table S8 ). Other major categories included cell adhesion molecules, extracellular matrix proteins, and signaling proteins ( Figure 3A ; Table S8 ).
PANTHER analysis also identified four major receptor categories with similar proportions in both cell populations: protein kinase receptors, cytokine receptors, ligand-gated ion channels, and G protein-coupled receptors ( Figure 3B ; Table S9 ). Transporters fell into three major subcategories that were equally represented in both populations: ion channels, cation transporters, and amino acid transporters ( Figure 3C ; Table S9 ). The similarities between neurons and precursors extended to other cell-surface proteins such as cell adhesion molecules and extracellular matrix proteins. However, some proteins were highly enriched in one or the other population. For example, many neurotransmitter receptors and ion channels, including multiple glutamate receptors, were enriched in neurons, while the insulin receptor, the netrin receptor DCC, and the tyrosine-protein kinase receptor ROR2 were enriched in precursors ( Figure 3D) .
We integrated the cell-surface proteome data with our transcriptome-based communication model by identifying receptors for ligands in the transcriptome model and overlapping them with those from the proteomic data ( Figure 3E ; Figure S2B ). This verified 32 receptors and 86 of 292 potential ligands in the transcriptome-based model. Most of these receptors were present on both populations, with the exception of Met and FGFR3, which were only detectable on neurons and enriched precursors, respectively. A comparison of the relative expression of the 32 validated receptors demonstrated a positive correlation between the log 2 fold-changes computed from the proteome versus the transcriptome data ( Figures 3F and 3G ), supporting the quantitative nature of this combined approach.
The Cortical Communication Model Identifies Potential In Vivo Interactions
To validate our communication model in vivo, we first asked whether the predicted ligands were expressed in the embryonic cortex, comparing them to the ligand mRNAs expressed at levels greater than or equal to FGF2 mRNA in previously published E13/14 cortex microarray data (Kusek et al., 2012; GEO: GSE38222) . We chose this as our cut-off, since FGF2 is expressed in and functionally relevant for the E13/14 cortex (Raballo et al., 2000) . 263 growth factor mRNAs were expressed in the cortex at this age (Table S10) , and 86% (227 of 263) of these were predicted in the transcriptome model ( Figure 4A ).
We also used Spearman rank correlation to compare relative ligand mRNA expression in E13/14 cortex, cortical neurons, and enriched precursors. This analysis ( Figure 4B) showed high correlations between all three groups. In contrast, there were low correlations between these groups and microglia ligand mRNAs expressed at levels higher than or equal to FGF2 that were extracted from previously published microarrays (Nomaru et al., 2014; GEO: GSE40714) . A statistical analysis by pairwise comparison demonstrated -log 10 -transformed and Bonferroni corrected p values between 33.8 and 35.6 for E13/ 14 cortex versus precursors and neurons, respectively, and of only 2.2 to 6.6 for microglia versus precursors and neurons ( Figure S3A ). As an additional control, we randomized the relative ligand orders. All of the Spearman rank correlations and their pairwise comparisons yielded values near zero ( Figure S3B ).
We next overlaid the E13/14 cortex ligands on the communication models. This refinement removed 52 ligands from the transcriptome-based communication network, but the large majority of the predicted interactions were maintained ( Figure 4C ). In the transcriptome plus proteome-based network ( Figure 4D ), 67 of 75 potential ligands were validated. Thus, the cultured neurons and enriched precursors were predictive of the in vivo environment.
One final potential caveat with this analysis is the relatively low percentage of intermediate progenitors in our precursor cultures versus the E13/14 cortex (5%-9% versus about 10%-20%, respectively). To ask whether this would impact our communication model, we extracted differentially expressed ligands and receptors from microarray data of the E14.5 cortex with or without intermediate progenitors due to conditional knockout of the Tbr2 gene (Nestin-Cre; EOMES fl/fl mice; Elsen et al., 2013;  GEO: GSE43387). Only three ligand and two receptor mRNAs were differentially expressed (p < 0.05 FDR) in the cortex without intermediate progenitors: Adcyap1 (2.8-fold increased), Angpt1 (4.2-fold increased), Fstl5 (1.6-fold increased), Sstr2 (0.5-fold decreased), and Nrp2 (1.8-fold increased). These ligands are included in our model, and these changes would have no impact on their inclusion.
Identification of Proneurogenic Factors Based on the Cortical Communication Model
We tested our refined communication model, asking whether it could predict ligands that regulate neurogenesis by focusing on 15 ligands expressed in E13/14 cortex (Figures 4C and 4D ; Table S10 ) but not previously characterized in this context. We examined eight ligands predicted by the integrated transcriptomic/proteomic model ( Figure 5A ) and seven predicted by the transcriptome model alone ( Figure 5B ). We plated E13 precursors in 96-well plates (50,000 cells/cm 2 ) and added individual ligands at 100 ng/mL for 3 days. Immunostaining for bIII-tubulin and high-content image analysis ( Figures 5C and 5D) showed that six ligands significantly increased newborn neurons: GDNF, Nrtn, macrophage inflammatory protein 1b (Mip1b, or CCL4), cardiotrophin-like cytokine factor 1 (CLCF1), IFNg, and neuropeptide Y (NPY). We validated these results by adding these ligands individually or together in similar culture experiments and manually counting cells positive for bIII-tubulin and Ki67. All six individual factors enhanced neurogenesis ( Figure 5E ) and, with the exception of CLCF1, significantly decreased Ki67-positive proliferating precursors ( Figure 5F ). Moreover, the combined factors almost doubled bIII-tubulin-positive neurons, and decreased proliferating precursors by almost 3-fold, an effect greater than that with any individual factors ( Figure 5G ). Of the six validated ligands, four were from the combined transcriptome/proteome model.
We further characterized five of the ligands, omitting CLCF1 since it had the most modest effects ( Figures 5E and 5F ). First, we asked whether they preferentially or differentially affected cortical neuron phenotypes when added to E13 precursors for 3 days. Immunostaining for bIII-tubulin and Cux1, which marks later-born, superficial neurons, or Ctip2, which marks deeper layer neurons showed that with and without added ligands, approximately 60% and 40% of neurons expressed Ctip2 and Cux1, respectively ( Figure 5H ). Second, we asked whether they affected gliogenesis when added to E13 precursors for 7 days. Immunostaining showed that in control cultures, about 1.5% of cells expressed the astrocyte marker GFAP, and only IFNg had any effect, increasing it to about 6% ( Figures 5I and  5J ). We confirmed that these GFAP-positive cells were likely to be astrocytes by colabeling them for a second astrocyte marker, ALDH1L1 ( Figures 5K and 5L) . We also assessed oligodendrogenesis by immunostaining similar cultures for MBP ( Figure 5M ). Under control conditions, about 4% of cells were MBP positive, and this was significantly decreased by all ligands except Mip1b ( Figure 5N ). Thus, four of the ligands selectively enhanced neurogenesis, while IFNg also promoted astrogenesis.
Since our transcriptome data indicated that all five of these ligands were expressed by cortical neurons, we asked whether they were responsible for the proneurogenic effects of neuronconditioned medium. To test this idea, we cultured E13 precursors with neuron-conditioned medium in the presence of previously validated neutralizing antibodies toward GDNF, Nrtn, IFNg, and Mip1b together with an NPY receptor (NPYR) antagonist. As a control, we used an equal concentration of non-specific IgG. Immunostaining 3 days later showed that neuron-conditioned medium enhanced neurons and decreased precursors and that the function-blocking antibody mixture abrogated these effects ( Figures 5O and 5P) . Thus, at least one of the five ligands is secreted by neurons to promote neurogenesis in culture.
The Proneurogenic Ligands Promote Differentiation of Radial Precursors into Intermediate Progenitors and Neurons In Vivo
To validate these ligands in vivo, we first confirmed their expression by qRT-PCR. All five ligand mRNAs were expressed in the cortex from E10 to E18, with differing profiles ( Figure 5Q ). Nrtn and Clcf1 mRNAs were relatively constant, Gdnf and Ifng mRNA levels increased several-fold from E13 to E15, while Mip1b and Npy mRNA levels were low at E13 and E15 with large increases during late embryogenesis.
We asked whether these ligands could promote neurogenesis in vivo, taking advantage of the fact that the apical endfeet of cortical radial precursors are adjacent to the lateral ventricles. We therefore injected a mixture of Nrtn, GDNF, IFNg, MIP1b, and NPY into the lateral ventricles of E13/14 mouse embryos in utero to increase their concentrations locally. At the same time, we injected the mothers with BrdU to assess proliferation. Two days later, we immunostained embryonic cortical sections for BrdU and the intermediate progenitor marker Tbr2, or SatB2, which labels almost all neurons born during this time period (Gallagher et al., 2013) (Figures 6A and 6B ; Figure S4A ). The combined ligands doubled BrdU-positive, Tbr2-positive intermediate progenitors and significantly increased BrdU-positive, SatB2-positive neurons relative to control injections (Figure 6C) . Immunostaining for BrdU and Pax6 or Ki67 showed that BrdU-positive, Pax6-positive, or Ki67-positive precursors were concomitantly decreased (Figures 6D-6G ; Figure S4A ).
IFNg, Nrtn, and GDNF Are Required for Normal Cortical Neurogenesis In Vivo
These data show that the combined ligands promoted neurogenic differentiation of radial precursor cells in vivo. We therefore asked whether the endogenous ligands were important for Figure 4D or (B) the transcriptome only model in Figure 4C . (C and D) 100 ng/mL of the selected ligands were added individually to E13 precursors, and cultures were immunostained 3 days later for bIII-tubulin and analyzed by high-content image analysis using CellProfiler. (C) shows bIII-tubulin immunostaining (top) and the objects identified in this image as neurons by CellProfiler (bottom; different colors are different objects), and (D) shows quantification, normalized to controls without ligands. *p < 0.05 (Student's unpaired t test with FDR correction for multiple comparisons), n = 4 experiments. (E-H) 100 ng/mL of proneurogenic ligands were added alone (E, F, and H) or together (G) to cultured E13 precursors, and bIII-tubulin-positive neurons (E and G), Ki67-positive precursors (F and G), or bIII-tubulin-positive neurons coexpressing Cux1 or Ctip2 (H) were determined by immunostaining and counting manually. *p < 0.05, **p < 0.01, ***p < 0.001, n = 3-4 experiments. A combination of Nrtn, GDNF, IFNg, MIP1b, and NPY (GF) or vehicle (Con) (A-G) or function blocking antibodies toward Nrtn, GDNF, IFNg, MIP1b, and a receptor antagonist toward NPYR (GF-block) or an equal amount of non-specific IgG (Con) (H-L) were injected into the lateral ventricles of E13/14 embryos coincident with maternal BrdU injection. Two days later, coronal cortical sections were immunostained for BrdU (red in all images) and Tbr2 (green, A, B, H, and I), Satb2 (green, A and B), Pax6 (green, D, E, H, and I), or Ki67 (green, D, E, H, and I) and quantified for the proportion of total BrdU-positive cells that were also positive for these markers (C, F, G, and J-L). Low-magnification images (A, D, and H) show the marker alone and the merged image with BrdU. High-magnification images of Tbr2 (B and I), SatB2 (B), and Pax6 and Ki67 (E and I) show the SVZ, cortical plate, and VZ/SVZ, respectively. In all images, arrowheads denote double-labeled cells. *p < 0.05, **p < 0.01, n = 9 sections each (3 each from 3 embryos, all from independent mothers). Scale bars represent 25 mm in (A), (D), and (H) and 10 mm in (B), (E), and (I). Error bars represent SEM. Also see Figure S4 .
Figure 7. Expression of Nrtn, GDNF, IFNg and Their Receptors in the Embryonic Cortex
(A and B) Individual function blocking antibodies toward Nrtn, GDNF, IFNg, MIP1b, or the NPYR antagonist were injected into E13/14 lateral ventricles, coincident with maternal BrdU injection. As controls, ventricles were injected with an equal amount of non-specific IgG (Con) or vehicle (NPYR veh). Two days later, sections were immunostained and quantified for BrdU-positive cells expressing Tbr2 (A) or Ki67 (B). *p < 0.05, **p < 0.01, ***p < 0.001, n = 3-5 embryos, 3 sections per embryo. (C) qRT-PCR analysis of Gfra1, Gfra2, Ret, and Ifngr1 mRNAs in E10, E13, E15, and E18 cortices. Levels were normalized to Gapdh and expressed as fold-change relative to E10.
(legend continued on next page)
neurogenesis by injecting the lateral ventricles of E13/14 embryos with function-blocking antibodies for Nrtn, GDNF, IFNg, MIP1b, and the NPY receptor antagonist. We coincidentally injected the mothers with BrdU. We confirmed that injected antibodies penetrated the cortical tissue by injecting non-specific goat IgG and immunostaining embryonic cortical sections 2 days later with an appropriate secondary antibody ( Figure S4B ). We also directly labeled the Nrtn antibody with an Alexa Fluor 555 tag and showed that 6 hr after injection into the lateral ventricles, it was found throughout the cortical tissue ( Figure S4C ).
Having validated this approach, we asked whether functionblocking antibodies affected neurogenesis. Immunostaining 2 days post-injection (Figures 6H and 6I ; Figure S4D) showed that, relative to control IgG, the function-blocking antibodies significantly decreased BrdU-positive, Tbr2-positive intermediate progenitors and increased the proportion of BrdU-positive, Pax6-positive radial precursors and Ki67-positive proliferating precursors ( Figures 6J-6L ). We asked which of the functionblocking antibodies mediated this effect, performing similar experiments with single antibodies or the NPY receptor antagonist. Immunostaining 2 days post-injection showed that the antibodies to Nrtn, GDNF, and IFNg all significantly decreased BrdU-positive, Tbr2-positive intermediate progenitors and increased BrdU-positive, Ki67-positive proliferating precursors ( Figures 7A and 7B ). In contrast, the MIP1b antibody and the NPY receptor antagonist had no effect on either parameter (Figures 7A and 7B) . Thus, the three proneurogenic ligands predicted by the combined transcriptome/proteome model, but not the two predicted only at the transcriptome level, were necessary for neurogenesis in vivo.
IFNg, Nrtn, and GDNF and Their Receptors Are Expressed in Radial Precursors and Newborn Cortical Neurons in the Embryonic Cortex
These data indicate that GDNF, Nrtn, and IFNg are important for appropriate genesis of intermediate progenitors and neurons. We further characterized expression of these ligands and their receptors using a number of approaches. First, qRT-PCR showed that the mRNAs encoding the relevant receptors, Gfra1, Gfra2, Ret, and Ifngr1, increased in expression in the cortex from E10 to E18 ( Figure 7C ). Second, western blots showed that IFNgRa, GFRa2, and Ret were all expressed at the protein level in the E13 cortex and that Ret was present in its phosphorylated, activated form ( Figure 7D) , consistent with the presence of GDNF family ligands. Third, we performed single-molecule fluorescence in situ hybridization (FISH) on sections of E12, E15, and E17 cortices (Figures 7G and 7H; Figures S5A-S5E ). This analysis demonstrated low but detectable expression of Gdnf, Nrtn, Ifng, Ret, Gfra1, Gfra2 , and Ifngr1 mRNAs throughout the E12 cortex ( Figures S5A and S5B) . At E15 and E17, their expression (except for Nrtn mRNA) was apparently increased, and all were present in both the VZ/SVZ precursor zones and the cortical plate ( Figure S5C ). High-magnification double-label FISH at E15 showed readily detectable expression of all mRNAs in radial precursors in the apical VZ ( Figure 7G ), and neurons in the cortical plate ( Figure 7H ). This analysis also showed that the ligand and receptor mRNAs (Gfra1 and Gdnf, Ret and Nrtn, Ifng and Ifngr1) were expressed in the same and/or adjacent cells in these regions (Figures 7G and 7H) . Similar results were obtained at E17 (Figures S5D and S5E) .
Finally, we immunostained the E13 cortex for IFNgRa and Ret ( Figures 7I and 7J) . Both IFNgRa and Ret were present throughout the cortex, and many cells in the VZ/SVZ were positive for both receptors. Immunostaining of E13 cultures confirmed this localization, showing that most Ki67-positive precursors were also positive for Ret and IFNgRa ( Figure 7K ).
The GDNF/Nrtn Coreceptor Ret and IFNgRa Are Necessary for Normal Cortical Neurogenesis These data suggest that GDNF, Nrtn, and IFNg act directly on radial precursors to regulate neurogenesis. To test this idea, we generated shRNAs for their receptors IFNgRa and Ret, confirming their efficacy in HEK293 cells cotransfected with expression constructs for the relevant receptors ( Figures 8A and 8B) . We also tested the two most efficacious of these shRNAs, shIFNGR1A and shRET2, in cultured E13 precursors, cotransfecting them with an EGFP expression vector. Immunostaining and image analysis 3 days later showed that Ret and IFNgRa immunofluorescence were significantly reduced in cells transfected with the relevant shRNA ( Figures 8C and 8D) .
We used these shRNAs to knock down receptor expression in apically localized radial precursors in vivo using in utero electroporation (Gauthier-Fisher et al., 2009 ). We first electroporated E13/14 cortices with control or Ret shRNAs together with a nuclear EGFP expression vector. Immunostaining of cortical sections 2 days post-electroporation showed that both shRET1 and shRET2 altered cellular distribution, with more EGFPpositive cells in the VZ and fewer in the SVZ and cortical plate relative to a control shRNA (Figures 8E and 8F ). This change in distribution was likely due to decreased neurogenesis, since Ret knockdown significantly decreased EGFP-positive, Tbr2-positive intermediate progenitors and increased proliferating radial precursors, as indicated by immunostaining for EGFP and Pax6 or Ki67 (Figures 8G-8J) .
We performed similar experiments to knock down IFNgRa. Immunostaining 2 days post-electroporation showed that both (D-F) Western blots of total protein from E13 cortices probed for IFNgRa (D, arrow), GFRa2 (E, arrow), Ret (F, left panel, arrow) , and the phosphorylated, activated Ret receptor (pRET) (F, right panel, arrow) . Size bars indicate molecular weight markers in kDa. shIFNGR1A and shIFNGR1B increased EGFP-positive cells in the VZ and decreased those in the SVZ relative to the control shRNA ( Figures 8K and 8L) . Moreover, EGFP-positive, Tbr2-positive intermediate progenitors were decreased by both shRNAs (Figures 8M and 8N) and EGFP-positive, Pax6-positive radial precursors and EGFP-positive, Ki67-positive proliferating precursors were increased following shIFNGR1A-mediated knockdown ( Figures 8M, 8O, and 8P) . Thus, consistent with the requirement for GDNF, Nrtn, and IFNg shown by the functionblocking antibody experiments, both Ret and IFNgRa are required for radial precursors to undergo appropriate levels of neurogenic differentiation.
DISCUSSION
In this study, we used an iterative systems biology approach to generate a growth factor communication network within and between embryonic cortical radial precursors and their newborn neuronal progeny, and based on this model, identified growth factors that regulate cortical neurogenesis in vivo. Our work supports a number of broad conclusions about these embryonic cortex growth factor interactions. First, we show that cortical precursors secrete factors that promote their own selfrenewal/proliferation, while cortical neurons secrete factors that promote neurogenesis. These findings make good biological sense. At early stages, precursors are the predominant cell type and the cortical microenvironment would be enriched in growth factors that promote proliferation and thus expansion of the cortex. As radial precursors start to generate neurons, the microenvironment would become enriched in proneurogenic factors that would enhance neurogenesis, and perhaps even initiate genesis of neurogenic intermediate progenitors, as we show here for IFNg, Nrtn, and GDNF.
Second, our communications model predicts a complex cortical growth factor environment with many previously uncharacterized autocrine and paracrine interactions. This complexity would not have been appreciated by traditional candidate factor analyses and may explain the diversity of NPC responses observed when analyzing single ligands in isolation (GauthierFisher and Miller, 2013) . This complexity might also reflect an unexpected heterogeneity within the cortical radial precursor pool, with subsets of precursors responding selectively to different environmental cues. Third, this same model predicted a large number of factors not previously considered in the embryonic cortex, three of which, IFNg, Nrtn, and GDNF, we validated as regulators of cortical neurogenesis. Many of these ''new'' ligands and receptors are predicted to be shared by precursors and neurons, suggesting that the same ligand-receptor pairs might sequentially regulate different aspects of cortical development. For example, previous work showed that the GDNF family regulates migration of cortical interneurons and excitatory neurons (Lundgren et al., 2012; Pozas and Ibá ñ ez, 2005) and our data show that this family also directly regulates neurogenesis itself.
Finally, our data imply that the ultimate cortical precursor decision to self-renew or differentiate is likely determined by multiple, convergent growth factor inputs. We propose that this convergence occurs, at least in part, at the intracellular level, as exemplified by the proneurogenic factors we identified here. GDNF and Nrtn bind to their preferred receptors, GFRa1 and GFRa2, respectively (Jing et al., 1997) and these ligand-coreceptor complexes associate with Ret, causing transphosphorylation of Ret and activation of downstream signaling pathways, including the MEK-ERK pathway (Worby et al., 1996) . IFNg binds to the high-affinity IFNgRa chain, inducing receptor oligomerization with the IFNgRb chain (Igarashi et al., 1994) and activating several downstream pathways, including the MEK-ERK pathway (Roy et al., 2002) . Intriguingly, we previously showed that a MEK-ERK-C/EBP pathway is essential for cortical neurogenesis (Mé nard et al., 2002) , providing one convergent proneurogenic pathway that all of these ligands would activate.
Systems-level and network analyses are now being applied to diverse areas of neuroscience (Parikshak et al., 2015) , including, for example, autism spectrum disorder (Parikshak et al., 2013) and neural cell heterogeneity (Zeisel et al., 2015 ). However, systems-level techniques are just now being applied to cell-cell communication, largely within the hematopoietic/immune system (Kirouac et al., 2010; Qiao et al., 2014) . Here, we have applied these approaches to obtain a broad overview of the growth factor environment in the developing cortex. Ongoing work connecting our cell interaction networks to spatially resolved single-cell analysis will ultimately allow us to understand how precursors and neurons integrate a wide variety of exogenous signals during normal and abnormal brain development.
EXPERIMENTAL PROCEDURES Animals and Reagents
All animal use was approved by the HSC Animal Care Committee in accordance with CCAC policies. CD1 mice (Charles River Laboratory) were used for all experiments. All plasmids, shRNAs, growth factor, and antibodies are described in the Supplemental Experimental Procedures.
Primary Cultures E12/13 cortical precursor cultures were prepared and transfected as previously described (Gallagher et al., 2013) with minor modifications. Purified cortical neurons were cultured from E16 cortices and were treated with 0.5 nM cytosine arabinoside (AraC) for 1 day to remove dividing cells. For coculture experiments, E12/13 precursors were plated directly on purified neurons in precursor medium. Conditioned medium was collected from neurons cultured at 90,000 cells/cm 2 for 2 days, or precursors cultured at 110,000 cells/cm 2 for 3 days.
Further details are in Supplemental Experimental Procedures.
In Utero Manipulations
In utero electroporation of E13/14 embryos was performed as described (Gauthier-Fisher et al., 2009) . A similar approach was used for growth factors and antibodies, injecting 1 mL containing 20 ng/mL of each growth factor and NPY, 40 ng/mL of each neutralizing antibody plus 1 uM BMS193885, 200 ng/ mL of single neutralizing antibodies or, as controls, 0.1% BSA, 200 ng/mL nonspecific goat IgG, or PBS. Mothers were injected i.p. with 400 mL of 20 mg/mL bromodeoxyuridine (BrdU) immediately following embryo reimplantation. Further details are in Supplemental Experimental Procedures.
Immunostaining and FISH
Immunostaining was performed essentially as described (Gallagher et al., 2013) . FISH was performed using the RNAScope Multiplex Fluorescent Assay kit (Advanced Cell Diagnostics). Images of immunostaining were collected using a Quorom spinning-disk confocal microscope system or a Zeiss Axio Imager M2 system with an X-Cite 120 LED light source and a C11440 Hamamatsu camera. For FISH, z stacks of confocal images were taken with optical slice thickness of 0.2 mm, and projected z stacked images are shown. Further details, FISH probes and antibodies are in Supplemental Experimental Procedures.
Western Blotting
For knockdowns, HEK293 cells were cultured and transfected and western blots were performed essentially as previously described (Gallagher et al., 2013 ) with minor modifications as described in Supplemental Experimental Procedures.
qRT-PCR RNA was isolated using the E.Z.N.A. Total RNA Kit I and E.Z.N.A. RNase-Free DNase I Set (Omega Bio-tek). cDNA was synthesized from 500 ng total RNA using RevertAid H Minus M-MulV Reverse Transcriptase (Thermo-Fisher), and qPCR was performed using Lightcycler 480 SYBR Green I Master mix (Roche) on a C1000 Touch Thermal Cycler (Bio-Rad). Gapdh mRNA was used as an endogenous control, and reactions were performed in triplicate. Primers are in Supplemental Experimental Procedures.
Microarray Analysis
Total RNA was isolated with the Ambion RiboPure RNA purification kit, analyzed to ensure RNA quality, and cDNA produced from 100 ng total RNA with the Ambion WT kit. 5.5 mg of labeled cDNA was hybridized on to Mouse Gene 2.0 ST arrays using the Affymetrix FS450_0002 hybridization protocol, and scanned using the Affymetrix GeneChip Scanner 3000. Microarray analysis was performed at the HSC TCAG. Microarray data have been deposited in the GEO database under the GSE84482 accession number.
Mass Spectrometry
Cell-surface mass spectrometry was carried out based on published protocols (McDonald et al., 2009; Schiess et al., 2009 ) and as described in the Supplemental Experimental Procedures. Data were analyzed using PEAK 7.5 software (Bioinformatics Solutions).
Analysis of Microarray and Mass Spectrometry Data
For microarray data, raw probe intensity values were background corrected, normalized, and transformed using the Oligo bioconductor package in R. To calculate differential gene expression, we used the limma bioconductor package to calculate Bayesian statistics and corrected using the Benjamini and Hochberg false discovery rate (FDR) procedure. Annotation was performed using the ''mogene20sttranscriptcluster.db'' library in R. Heatmaps were prepared in R using the heatmap.2 function on averaged log 2 RMAnormalized or label-free quantitative proteomic data. The cluster analysis was performed using the complete linkage method of a Euclidian distance matrix. GO analysis was performed using the GOstats bioconductor package in R. The gene ''universe'' in these analyses was all of the mapped keys in the org.Mm.egGO databases. Spearman rank correlation and pairwise statistical analysis were performed using the corrplot package and cor.test function in R. WGCNA analysis was performed with log 2 RMAnormalized data using the WGCNA package with default parameters and a soft-thresholding power of 6. Further details are in Supplemental Experimental Procedures.
PERT Analysis and Network Construction As previously described (Qiao et al., 2012 (Qiao et al., , 2014 , microarray data were preprocessed with PERT to correct ligand/receptor values for changes in a heterogeneous population of cells, and the cell-cell intraction network was constructed with these corrected values as per the flow chart in Figure S1C . For more details, see Supplemental Experimental Procedures.
Statistical Analyses
For single group comparisons, we used two-tailed unpaired Student's t tests and for multi-group comparisons, ANOVA followed by a Dunnett's post hoc analysis. For the high-content analysis, we used two-tailed unpaired Student's t tests corrected by the Benjamini and Hochberg false-discover rate procedure. In all cases, GraphPad Prism (version 5.0.3) was used.
ACCESSION NUMBERS
The accession number for them microarray data reported in this paper is GEO: GSE84482. 
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